Comparing the effects of Berberine, Curcumine and gonadotropin-releasing hormone agonist (GnRH) on uterine leiomyoma volume , a controlled, randomized clinical trials

Semnan University of Medical Sciences0 个研究点目标入组 102 人开始时间: 待定最近更新: 2022年3月8日

试验速览

暂无简介。

•Non-menopausal women between the ages of 18 and 45, who have a myoma larger than 5 cm that have abnormal uterine bleeding, pelvic pain, dysmenorrhea, and a compressive effect.
•Women with myomas larger than or equal to 5 cm who have other myomas (s) less than 2 cm in size

•Women with extra myoma (s) greater than or equal to 2 cm
•Women with uterine myoma who have been treated with any type of estrogen or progesterone in less than a month and hormonal implants in the last 3 months
•Women with a history of major medical illness and / or previous drug or surgical treatment of uterine leiomyomas
•All women with myomas 2-5 cm in size were excluded from the study
•Patients receiving antihypertensive drugs, beta-blockers and calcium channel blockers, and ACE inhibitors were excluded from the study due to possible drug interactions
•Patients who develop side effects during the study will be excluded from the study

发起方

Semnan University of Medical Sciences